354 related articles for article (PubMed ID: 7780654)
1. Angiotensin-converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco-2) cells.
Thwaites DT; Cavet M; Hirst BH; Simmons NL
Br J Pharmacol; 1995 Mar; 114(5):981-6. PubMed ID: 7780654
[TBL] [Abstract][Full Text] [Related]
2. Substrate specificity of the di/tripeptide transporter in human intestinal epithelia (Caco-2): identification of substrates that undergo H(+)-coupled absorption.
Thwaites DT; Hirst BH; Simmons NL
Br J Pharmacol; 1994 Nov; 113(3):1050-6. PubMed ID: 7858848
[TBL] [Abstract][Full Text] [Related]
3. H(+)-coupled dipeptide (glycylsarcosine) transport across apical and basal borders of human intestinal Caco-2 cell monolayers display distinctive characteristics.
Thwaites DT; Brown CD; Hirst BH; Simmons NL
Biochim Biophys Acta; 1993 Sep; 1151(2):237-45. PubMed ID: 8373798
[TBL] [Abstract][Full Text] [Related]
4. Transepithelial glycylsarcosine transport in intestinal Caco-2 cells mediated by expression of H(+)-coupled carriers at both apical and basal membranes.
Thwaites DT; Brown CD; Hirst BH; Simmons NL
J Biol Chem; 1993 Apr; 268(11):7640-2. PubMed ID: 8463293
[TBL] [Abstract][Full Text] [Related]
5. Gamma-Aminobutyric acid (GABA) transport across human intestinal epithelial (Caco-2) cell monolayers.
Thwaites DT; Basterfield L; McCleave PM; Carter SM; Simmons NL
Br J Pharmacol; 2000 Feb; 129(3):457-64. PubMed ID: 10711343
[TBL] [Abstract][Full Text] [Related]
6. Transepithelial dipeptide (glycylsarcosine) transport across epithelial monolayers of human Caco-2 cells is rheogenic.
Thwaites DT; McEwan GT; Hirst BH; Simmons NL
Pflugers Arch; 1993 Oct; 425(1-2):178-80. PubMed ID: 8272376
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of peptide transporters in MDCKII-MDR1 cell line as a model for oral absorption studies.
Agarwal S; Jain R; Pal D; Mitra AK
Int J Pharm; 2007 Mar; 332(1-2):147-52. PubMed ID: 17097248
[TBL] [Abstract][Full Text] [Related]
8. Transport of angiotensin-converting enzyme inhibitors by H+/peptide transporters revisited.
Knütter I; Wollesky C; Kottra G; Hahn MG; Fischer W; Zebisch K; Neubert RH; Daniel H; Brandsch M
J Pharmacol Exp Ther; 2008 Nov; 327(2):432-41. PubMed ID: 18713951
[TBL] [Abstract][Full Text] [Related]
9. Direct assessment of dipeptide/H+ symport in intact human intestinal (Caco-2) epithelium: a novel method utilising continuous intracellular pH measurement.
Thwaites DT; Hirst BH; Simmons NL
Biochem Biophys Res Commun; 1993 Jul; 194(1):432-8. PubMed ID: 8333858
[TBL] [Abstract][Full Text] [Related]
10. H(+)-coupled alpha-methylaminoisobutyric acid transport in human intestinal Caco-2 cells.
Thwaites DT; McEwan GT; Hirst BH; Simmons NL
Biochim Biophys Acta; 1995 Mar; 1234(1):111-8. PubMed ID: 7880851
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of intestinal dipeptide transport by the neuropeptide VIP is an anti-absorptive effect via the VPAC1 receptor in a human enterocyte-like cell line (Caco-2).
Anderson CM; Mendoza ME; Kennedy DJ; Raldua D; Thwaites DT
Br J Pharmacol; 2003 Feb; 138(4):564-73. PubMed ID: 12598410
[TBL] [Abstract][Full Text] [Related]
12. Stability and in vitro absorption of captopril, enalapril and lisinopril across the rat intestine.
Zhou XH; Li Wan Po A
Biochem Pharmacol; 1994 Mar; 47(7):1121-6. PubMed ID: 8161340
[TBL] [Abstract][Full Text] [Related]
13. The role of the proton electrochemical gradient in the transepithelial absorption of amino acids by human intestinal Caco-2 cell monolayers.
Thwaites DT; McEwan GT; Simmons NL
J Membr Biol; 1995 Jun; 145(3):245-56. PubMed ID: 7563025
[TBL] [Abstract][Full Text] [Related]
14. The apical uptake transporter of levofloxacin is distinct from the peptide transporter in human intestinal epithelial Caco-2 cells.
Fukumori S; Murata T; Takaai M; Tahara K; Taguchi M; Hashimoto Y
Drug Metab Pharmacokinet; 2008; 23(5):373-8. PubMed ID: 18974615
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
Udupa EG; Rao NM
Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434
[TBL] [Abstract][Full Text] [Related]
16. Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicles: interaction of ACE inhibitors with high-affinity H+/peptide symporter.
Lin CJ; Akarawut W; Smith DE
Pharm Res; 1999 May; 16(5):609-15. PubMed ID: 10350000
[TBL] [Abstract][Full Text] [Related]
17. Function and immunolocalization of overexpressed human intestinal H+/peptide cotransporter in adenovirus-transduced Caco-2 cells.
Hsu CP; Walter E; Merkle HP; Rothen-Rutishauser B; Wunderli-Allenspach H; Hilfinger JM; Amidon GL
AAPS PharmSci; 1999; 1(3):E12. PubMed ID: 11741208
[TBL] [Abstract][Full Text] [Related]
18. Na(+)-independent, H(+)-coupled transepithelial beta-alanine absorption by human intestinal Caco-2 cell monolayers.
Thwaites DT; McEwan GT; Brown CD; Hirst BH; Simmons NL
J Biol Chem; 1993 Sep; 268(25):18438-41. PubMed ID: 8395502
[TBL] [Abstract][Full Text] [Related]
19. Intestinal absorption mechanism of dipeptide angiotensin converting enzyme inhibitors of the lysyl-proline type: lisinopril and SQ 29,852.
Friedman DI; Amidon GL
J Pharm Sci; 1989 Dec; 78(12):995-8. PubMed ID: 2559191
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism for the relative binding affinity to the intestinal peptide carrier. Comparison of three ACE-inhibitors: enalapril, enalaprilat, and lisinopril.
Swaan PW; Stehouwer MC; Tukker JJ
Biochim Biophys Acta; 1995 May; 1236(1):31-8. PubMed ID: 7794953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
